BJL
HCAT icon

Brighton Jones LLC’s Health Catalyst HCAT Stock Holding History

Brighton Jones LLC’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,626
Closed -$408K – 505
2022
Q1 		$408K Buy
15,626
+230
+1% +$6.53K 0.02% 310
2021
Q4 		$610K Hold
15,396
– – 0.03% 241
2021
Q3 		$770K Sell
15,396
-14,054
-48% -$766K 0.04% 191
2021
Q2 		$1.64M Buy
29,450
+15,396
+110% +$820K 0.08% 107
2021
Q1 		$657K Buy
+14,054
New +$681K 0.04% 199

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return